TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in Leukemia Research
- Vol. 35 (2), 272-274
- https://doi.org/10.1016/j.leukres.2010.08.023
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damageBlood, 2009
- Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialBlood, 2009
- The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and ChemorefractorinessClinical Cancer Research, 2009
- TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtypeLeukemia Research, 2009
- Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-upBlood, 2008
- The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotypeLeukemia, 2008
- A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable diseaseLeukemia, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Screening for copy‐number alterations and loss of heterozygosity in chronic lymphocytic leukemia—A comparative study of four differently designed, high resolution microarray platformsGenes, Chromosomes and Cancer, 2008
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000